Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Editorial comment.

Epstein JI.

Urology. 2011 Jun;77(6):1414-5; author reply 1415. doi: 10.1016/j.urology.2010.11.037. No abstract available.

PMID:
21624604
2.

Ability of linear length of positive margin in radical prostatectomy specimens to predict biochemical recurrence.

Cao D, Humphrey PA, Gao F, Tao Y, Kibel AS.

Urology. 2011 Jun;77(6):1409-14. doi: 10.1016/j.urology.2010.10.059.

PMID:
21256540
3.

Editorial comment.

Canes D.

Urology. 2011 Apr;77(4):974; author reply 974-5. doi: 10.1016/j.urology.2010.07.518. No abstract available.

PMID:
21477728
4.

Prostate cancer does not influence androgen levels: a radical prostatectomy cohort study.

De Nunzio C, Carluccini A, Cicione A, Squillacciotti S, Trucchi A, Cantiani A, Leonardo C, Tubaro A.

Urol Int. 2011;86(2):161-6. doi: 10.1159/000322964.

PMID:
21252482
5.

Radical prostatectomy in high-grade prostate cancer, salvage and adjuvant radiotherapy.

Brodak M, Kosina J, Holub L, Louda M, Odrazka K, Dolezel M, Sefrová J, Jansa J, Pacovsky J.

Urol Int. 2011;86(2):146-51. doi: 10.1159/000320494.

PMID:
20975252
6.

Re: Tollefson et al.: Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy (Urology 2011;77:1161-1165).

Schwartz GG, Skinner HG.

Urology. 2011 Jun;77(6):1511-2; author reply 1512. doi: 10.1016/j.urology.2010.12.064. No abstract available.

PMID:
21624612
7.

Radical perineal prostatectomy versus radical retropubic prostatectomy after previous prostate surgery: surgical and functional outcomes.

Imperatore V, Cantiello F, Fusco F, Iannuzzo M, Di Meo S, Imbimbo C, Mirone V.

Urol Int. 2011;86(2):140-5. doi: 10.1159/000317326.

PMID:
21116105
8.

Stage-by-stage effects of surgical margin status on biochemical failure after radical prostatectomy in patients with clinically localized prostate cancer.

Akdemir AO, Ozden C, Oztekin CV, Aktas BK, Cetinkaya M, Memis A, Doluoglu OG.

Urol Int. 2011;86(2):156-60. doi: 10.1159/000322840.

PMID:
21311164
9.

Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.

Park SY, Kim CK, Park BK, Lee HM, Lee KS.

Eur Radiol. 2011 May;21(5):1111-8. doi: 10.1007/s00330-010-1999-9.

PMID:
21046403
12.

Radical prostatectomy for localized prostate cancer.

Middleton RG.

Semin Urol. 1983 Aug;1(3):229-35.

PMID:
6678471
13.

Editorial comment.

Garnick MB.

Urology. 2010 Jun;75(6):1428-30; author reply 1430. doi: 10.1016/j.urology.2009.07.1272. No abstract available.

PMID:
20513506
14.

Editorial comment on: adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?

Da Pozzo L.

Eur Urol. 2008 Sep;54(3):541-2. doi: 10.1016/j.eururo.2008.06.061. No abstract available.

PMID:
18602740
15.

Positive margins in urological oncology.

Koch MO.

J Urol. 2007 Dec;178(6):2249. No abstract available.

PMID:
17936808
16.

[Prostatic cancer: clinical situation and treatment strategy].

Jacobi GH, Hohenfellner R.

Chirurg. 1981 Sep;52(9):561-9. German. No abstract available.

PMID:
7297207
17.

[Significance of radical surgery of prostatic carcinoma].

Okada K, Konno T, Hachiya T, Kawata N, Kobayashi M, Hirano D, Yoshida T, Kitamura K, Yasuoka S, Saitoh T, et al.

Nihon Hinyokika Gakkai Zasshi. 1987 Nov;78(11):1998-2003. Japanese. No abstract available.

PMID:
3450936
18.

Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?

Klein EA, Ciezki J, Kupelian PA, Mahadevan A.

Urol Oncol. 2009 Jan-Feb;27(1):67-71. doi: 10.1016/j.urolonc.2008.04.001. Review.

PMID:
19111801
19.

Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.

van der Poel HG.

Eur Urol. 2009 May;55(5):1133-4. doi: 10.1016/j.eururo.2008.06.055. No abstract available.

PMID:
18585847
Items per page

Supplemental Content

Support Center